Table 2.
Clinical parameters for the study groups
|
Control |
POAG |
PXS |
PXG |
|
|---|---|---|---|---|
| (n = 44) | (n = 36) | (n = 44) | (n = 44) | |
|
AGE(years) |
75.27 ± 5.66 (63–86) |
75.74 ± 7.4 (59–86) (p = 0.96) |
75.76 ±5.15 (61–84) (p = 0.96) |
75.96 ± 6.37 (64–88) (p = 0.96) |
|
IOP (mm Hg) |
14 ± 2.35 (9–17) |
19 ±6.6 (10–40) |
14.7 ± 3 (9–20) |
21.1 ±9,3 (8–38) |
|
Optic nerve c/d ratio |
0.25 ± 0.053 (0.1–0.4) |
0.62 ± 0.17 (0.4-0.9) |
0.28 ±0.071 (0.2–0.4) |
0.68 ± 0.16 (0.4–0.9) |
| Number of topical medications | nil |
1 (49%) |
nil |
1 (9%) |
| |
2 (23%) |
|
2 (13%) |
|
| |
3 (11%) |
|
3 (47%) |
|
| 4 (6%) | 4 (22%) |
POAG: Primary open angle glaucoma, PXS: Pseudoexfoliation, PXG: Pseudoexfoliation glaucoma, c/d: cup-to-disc ratio. Results are presented as mean ± SD (range).
p values refer to the comparison between each study group versus controls with the Kolmogorov-Smirnoff test.